Tanya Trakarnphornsombat
@watanyatra.bsky.social
Postdoctoral Training Fellow at the Institute of Cancer Research, London
So proud of Dan for winning the poster prize — and it was his very first poster! What a great start!
QMUL Centre for Epigenetics @qmulepigenetics.bsky.social · last yr.Congratulations to poster prize winners Daniel Price and Maximilian H. Fitz-James and @manthan5277.bsky.social . Sponsored by @gensocuk.bsky.social and cosponsored by the @biochemsoc.bsky.social
The Transcription and Chromatin UK Meeting is back for 2025! Don't miss out — register your interest: www.biochemistry.org/events-and-t... @biochemsoc.bsky.social
Transcription and Chromatin UK 2025
Transcription and Chromatin UK brings together the rich transcription and epigenetics community in the UK and leading experts from abroad, and will feature all aspects of transcription and chromatin r...
biochemistry.org
🚨 Preprint alert 🚨 Excited to share our work on "Ab-trapping," an antibody artifact causing misleading peripheral ("rim") staining in imaging & genomics (IF, CUT&Tag, CUT&RUN). Antibodies fail to penetrate structures, accumulating at the periphery. A 🧵👇 doi.org/10.1101/2025...
Ab-trapping - a peripheral staining artifact in antibody-based microscopy and genomics
Antibodies (Ab) are essential for detecting specific epitopes in microscopy and genomics, but can produce artifacts leading to erroneous interpretations. Here, we characterize a novel artifact, Ab-tra...
doi.org
CRISPR genome editing clicks for amyloid cardiomyopathy. nejm.org/doi/full/10.... A Phase 1 study with marked reduction of serum TTR
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy | NEJM
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, often fatal disease. Nexiguran ziclumeran (nex-z) is an investigational therapy based on CRISPR-Cas9 (clustered regularly i...
nejm.org
Follow the Institute of Cancer Research on our new Bluesky account. Moving from X - @icrlondon.bsky.social
